The Antitumor Effects Of Regorafenib In Vivo Are Puma Dependent A Nude

The antitumor effects of regorafenib in vivo are PUMA dependent. A ...
The antitumor effects of regorafenib in vivo are PUMA dependent. A ...
The antitumor effects of regorafenib in vivo are PUMA-dependent. A Nude ...
The antitumor effects of regorafenib in vivo are PUMA-dependent. A Nude ...
The antitumor effects of regorafenib in vivo are PUMA dependent. A ...
The antitumor effects of regorafenib in vivo are PUMA dependent. A ...
The antitumor effects of regorafenib in vivo are PUMA-dependent. A Nude ...
The antitumor effects of regorafenib in vivo are PUMA-dependent. A Nude ...
The antitumor effects of regorafenib in vivo are PUMA dependent. A ...
The antitumor effects of regorafenib in vivo are PUMA dependent. A ...
The antitumor effects of regorafenib in vivo are PUMA-dependent. A Nude ...
The antitumor effects of regorafenib in vivo are PUMA-dependent. A Nude ...
The antitumor effects of regorafenib in vivo are PUMA-dependent. A Nude ...
The antitumor effects of regorafenib in vivo are PUMA-dependent. A Nude ...
The antitumor effects of AZD8055 in vivo are PUMA dependent. a-b Nude ...
The antitumor effects of AZD8055 in vivo are PUMA dependent. a-b Nude ...
The antitumor effects of copanlisib in vivo are PUMA-dependent. A Nude ...
The antitumor effects of copanlisib in vivo are PUMA-dependent. A Nude ...
PUMA mediates the chemosensitization effects of regorafenib in vitro ...
PUMA mediates the chemosensitization effects of regorafenib in vitro ...
In vivo evaluation of the combination of regorafenib and 5-FU as a ...
In vivo evaluation of the combination of regorafenib and 5-FU as a ...
Mcl-1 degradation contributes to the in vivo antitumor activity of ...
Mcl-1 degradation contributes to the in vivo antitumor activity of ...
FBW7 and Mcl-1 degradation contribute to the in vivo antitumor effects ...
FBW7 and Mcl-1 degradation contribute to the in vivo antitumor effects ...
Antitumor activity of regorafenib in vivo against various subcutaneous ...
Antitumor activity of regorafenib in vivo against various subcutaneous ...
Effect of regorafenib and topotecan on the growth of S1 tumors in nude ...
Effect of regorafenib and topotecan on the growth of S1 tumors in nude ...
In vivo antitumor efficacy. (a) Schematic illustration of the drug ...
In vivo antitumor efficacy. (a) Schematic illustration of the drug ...
Antitumor effects of regorafenib and sorafenib in preclinical models of ...
Antitumor effects of regorafenib and sorafenib in preclinical models of ...
Regorafenib upregulates the expression of p53 both in vivo and in ...
Regorafenib upregulates the expression of p53 both in vivo and in ...
Activation of p65 mediates PUMA induction in response to regorafenib ...
Activation of p65 mediates PUMA induction in response to regorafenib ...
(PDF) Synergistic antitumor activity of regorafenib and rosuvastatin in ...
(PDF) Synergistic antitumor activity of regorafenib and rosuvastatin in ...
Antitumor activity of regorafenib alone and in combination against ...
Antitumor activity of regorafenib alone and in combination against ...
In vivo tumor imaging and antitumor effect. (A) Fluorescence image of ...
In vivo tumor imaging and antitumor effect. (A) Fluorescence image of ...
Synergistic antitumor activity of regorafenib and rosuvastatin in ...
Synergistic antitumor activity of regorafenib and rosuvastatin in ...
Synergistic antitumor activity of regorafenib and rosuvastatin in ...
Synergistic antitumor activity of regorafenib and rosuvastatin in ...
PUMA is required for the apoptotic and antitumour effects of ...
PUMA is required for the apoptotic and antitumour effects of ...
Rosuvastatin significantly promoted the antitumor effects of ...
Rosuvastatin significantly promoted the antitumor effects of ...
In vivo antitumor effect of different drug formulations. (A) Tumor ...
In vivo antitumor effect of different drug formulations. (A) Tumor ...
Antitumor activity of regorafenib alone and in combination with ...
Antitumor activity of regorafenib alone and in combination with ...
In vivo antitumor study. (A) Schematic illustration of in vivo ...
In vivo antitumor study. (A) Schematic illustration of in vivo ...
Din enhanced the tumor inhibitory effect of regorafenib in vivo. Male ...
Din enhanced the tumor inhibitory effect of regorafenib in vivo. Male ...
Antitumor Effect of Regorafenib on MicroRNA Expression in ...
Antitumor Effect of Regorafenib on MicroRNA Expression in ...
Antitumor activity of regorafenib alone and in combination with ...
Antitumor activity of regorafenib alone and in combination with ...
Upregulation of PUMA expression by regorafenib correlates with ...
Upregulation of PUMA expression by regorafenib correlates with ...
Regorafenib had immunomodulatory effects, which are independent of ...
Regorafenib had immunomodulatory effects, which are independent of ...
Synergistic effect of regorafenib and CB2 agonists in vivo. (A ...
Synergistic effect of regorafenib and CB2 agonists in vivo. (A ...
Effect of regorafenib on the main cancer-related signaling pathways and ...
Effect of regorafenib on the main cancer-related signaling pathways and ...

Loading image details...

Source
Dimensions